Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
| Autor: | Pavel, Marianne E, Hainsworth, John D, Baudin, Eric, Peeters, Marc, Hörsch, Dieter, Winkler, Robert E, Klimovsky, Judith, Lebwohl, David, Jehl, Valentine, Wolin, Edward M, Öberg, Kjell, Van Cutsem, Eric, Yao, James C |
|---|---|
| Zdroj: | In The Lancet 10-16 December 2011 378(9808):2005-2012 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|